Table 5. Clinicopathological Characteristics of High GP73 Expression in HCC Tissuesa.
| Variables | N | GP73 High Expression | χ2 | P Value |
|---|---|---|---|---|
| Tumor diameter | 0.052 | .819 | ||
| ≤ 2.0 cm | 17 (19.32) | 11 (64.71) | ||
| > 2.0 cm | 71 (80.68) | 48 (67.61) | ||
| Differentiation | 0.209 | .647 | ||
| Well-Moderate | 75 (85.23) | 51 (68.00) | ||
| Poor | 13 (14.77) | 8 (61.54) | ||
| AFP, ng/mL | 3.695 | .055 | ||
| ≤ 400 | 64 (72.73) | 40 (62.50) | ||
| > 400 | 24 (27.27) | 19 (79.17) | ||
| Liver cirrhosis | 0.147 | .702 | ||
| Yes | 63 (71.59) | 43 (68.25) | ||
| No | 25 (28.41) | 16 (64.00) | ||
| Lymph node metastasis | 6.940 | .008 | ||
| Yes | 25 (28.41) | 22 (88.00) | ||
| No | 63 (71.59) | 37 (58.73) | ||
| Gross classification | 6.311 | .012 | ||
| Multifocal | 16 (18.18) | 15 (93.75) | ||
| Unifocal | 72 (81.82) | 44 (61.11) | ||
| HBV infection | 4.803 | .028 | ||
| Positive | 72 (81.81) | 52 (72.22) | ||
| Negative | 16 (18.18) | 7 (43.75) | ||
| TNM Staging | 4.887 | .027 | ||
| Stage I - II | 70 (79.55) | 43 (61.43) | ||
| Stage III - IV | 18 (20.45) | 16 (88.89) | ||
| Five-year survival | 5.206 | .023 | ||
| Yes | 23 (26.14) | 11 (47.83) | ||
| No | 65 (73.86) | 48 (73.85) |
Abbreviations: AFP, α-fetoprotein; GP73, Golgi protein 73; HBV, hepatitis B virus infection; TNM, tumor node metastasis.
aData are presented as No. (%).